Moxy Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 8.84 M
as on 13-12-2024
- Company Age 39 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.10 M
as on 13-12-2024
- Satisfied Charges ₹ 1.79 Cr
as on 13-12-2024
- Revenue -2.71%
(FY 2022)
- Profit 8.22%
(FY 2022)
- Ebitda 39.48%
(FY 2022)
- Net Worth -30.06%
(FY 2022)
- Total Assets -24.90%
(FY 2022)
About Moxy Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.84 M.
The company currently has active open charges totaling ₹1.10 M. The company has closed loans amounting to ₹1.79 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashok Shinde, Chinmay Upadhyay, and Chandrakant Patel serve as directors at the Company.
- CIN/LLPIN
U65910GJ1985PTC007675
- Company No.
007675
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Moxy Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Shinde  | Director | 15-Jul-2016 | Current |
| Chinmay Upadhyay | Director | 29-Jan-2024 | Current |
| Chandrakant Patel | Director | 10-Jul-2020 | Current |
Financial Performance and Corporate Structure Insights of Moxy Laboratories.
Moxy Laboratories Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 2.71% decrease. The company also saw a slight improvement in profitability, with a 8.22% increase in profit. The company's net worth observed a substantial decline by a decrease of 30.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Moxy Laboratories?
In 2022, Moxy Laboratories had a public holding of 3.24%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 12 Nov 2021 | ₹1.10 M | Open |
Others Creation Date: 05 Jul 2018 | ₹3.00 M | Satisfied |
State Bank Of India Creation Date: 31 Oct 2005 | ₹5.50 M | Satisfied |
How Many Employees Work at Moxy Laboratories?
Unlock and access historical data on people associated with Moxy Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Moxy Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Moxy Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
